2-Ribofuranosyl-3-Iodo-2,3-Dihydro-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine

Star0

DB02416ExperimentalSmall molecule

2-Ribofuranosyl-3-Iodo-2,3-Dihydro-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine: Overview.

Formula / weight: C₁₀H₁₄IN₅O₄ · 395.1537 g/mol (avg)

Resolves to

Compound

ChEBI45448PubChem17754151

Structure

InChIKeyIPMOTTQXPAXTMS-CKVFBBIQSA-NSMILES[H][C@]1(I)NN(C2=NC=NC(N)=C12)[C@]1([H])O[C@]([H])(CO)[C@@]([H])(O)[C@@]1([H])O

Which companies are running trials of 2-Ribofuranosyl-3-Iodo-2,3-Dihydro-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account